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Background: Bovine Amyloidotic Spongiform Encephalopathy (BASE) is a variant of classical BSE that affects cows
and can be transmitted to primates and mice. BASE is biochemically different from BSE and shares some molecular
and histo-pathological features with the MV2 sub-type of human sporadic Creutzfeld Jakob Disease (sCJD).
Results: The present work examined the effects of BASE on gene expression in circulating immune cells. Ontology
analysis of genes differentially expressed between cattle orally challenged with brain homogenate from cattle
following intracranial inoculation with BASE and control cattle identified three main pathways which were affected.
Within the immune function pathway, the most affected genes were related to the T cell receptor-mediated T cell
activation pathways. The differential expression of these genes in BASE challenged animals at 10,12 and 24 months
following challenge, vs unchallenged controls, was investigated by real time PCR.
Conclusions: The results of this study show that the effects of prion diseases are not limited to the CNS, but
involve the immune system and particularly T cell signalling during the early stage following challenge, before the
appearance of clinical signs.
Keywords: Bovine Amyloidotic Spongiform Encephalopathy (BASE), Transmissible Spongiform Encephalopathies
(TSEs), Immune function, CattleBackground
BSE (Bovine Spongiform Encephalopathy) is a fatal neu-
rodegenerative disorder that affects cattle, which was
first identified in 1986 in the UK [1]. Following the first
description of BSE, the number of cases rapidly in-
creased and reached epidemic proportions in the UK
cattle population. A relatively small number of BSE cases
were also found in cattle in other countries. In 1990 the
appearance of a new variant of Creutzfeldt Jakob* Correspondence: john.williams001@adelaide.edu.au
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unless otherwise stated.disease (vCJD) in humans was linked to food borne
transmission of BSE, which caused major concerns for
public health [2].
The key event in the pathobiology of BSE and other
Transmissible Spongiform Encephalopathies (TSEs) is
the conversion of the cellular prion protein (PrPc) into
an insoluble, protease-resistant isoform, PrPres. This
aberrant form of the protein eventually accumulates in
the central nervous system (CNS) and is associated with
the onset of clinical disease [3]. In the initial phases of
classical transmissible prion diseases, such as scrapie
and TSE infection via the oral route, PrPres propagates
in the peripheral lymphoreticular system before trans-
mission to the CNS [4]. Progression of classical TSEl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mune cells, however, the absence of functional lympho-
cytes does not impair prion pathogenesis and spread to
the CNS [5,6]. The pathobiology of spontaneous and
atypical prion diseases, however, is not well understood.
The primary biological function of PrPc, a surface
glycoprotein encoded by the PRNP gene, is still unclear.
Many studies suggest that it may play a role in the
regulation of ion channels and neuronal excitation [7].
PrP may also be linked to immune function [6,8-10] as
PrPc is expressed by several immune cell subsets,
including T and B lymphocytes, CD34+ hematopoietic
precursors, dendritic cells (DC), natural killer cells (NK),
granulocytes and monocytes [11-13]. The highest expres-
sion of PrPc is observed in a sub-population of T lympho-
cytes, the CD4+ CD25+ FoxP3+ T regulatory cells [14].
PrPc is implicated in several immune processes, including
T cell activation and differentiation, immune memory,
monocyte activation, inflammation, DC differentiation
and activation, and apoptosis of antigen presenting cells
(APC) [8,9,15]. PRNP knock-out mice display impaired
renewal of the CD34+ cell precursor pool, an abnormal
inflammatory response and phagocytosis, limited capacity
of DC to act as APC and impaired T cell activation in re-
sponse to Concanavalin A (Con-A), which requires a
functional T cell receptor (TCR) pathway [8,16]. Other
studies have shown that PrPc interacts with the TCR in
the activation of T cells [9,17,18].
All the cases of BSE identified during the major out-
break in the UK were of the same strain type [19].
However, an atypical form of BSE, Bovine Amyloidotic
Spongiform Encephalopathy (BASE), was discovered in
Italy in 2004 in two old (11 and 15 year old) asymptom-
atic cows post mortem [19]. Other atypical forms of
BSE were subsequently reported in France, Germany
and Japan [19-22]. The frequency of atypical BSE may
be similar to the occurrence of sporadic CJD, which is
about 1 per million individuals [23]. BASE can be bio-
chemically differentiated from BSE by the different mo-
bility of PrP fragments on gel electrophoresis. BASE
can also be distinguished from BSE histo-pathologically
based on differences in the distribution of vacuoles in
the brain. BASE shares molecular and histo-
pathological features with the MV2 sub-type of human
sporadic CJD (sCJD) [19,22]. BASE has been experi-
mentally transmitted to cattle, primates, and mice
[24-26].
In an earlier study [27] we identified genes differen-
tially expressed between healthy cattle and cattle orally
challenged with BASE at 12 months post challenge by
microarray analysis. The present work examines samples
from the same experimental oral challenge of cattle with
BASE at additional time points post challenge, prior to
the onset of disease, to assess the effects of the challengeon the expression of genes related to the T cell receptor
pathway in circulating immune cells.
Methods
Animal resource and RNA preparation
Eleven Holstein heifers of approximately 4 months of
age were orally challenged with 50 g brain homogenate
from cows inoculated intracranially with BASE (see ref-
erence [27]). Challenged animal were regularly clinically
monitored and blood (10 ml in EDTA) was collected at
3 month intervals from all animals from 6 months to
24 months post challenge. Ten, age and sex matched
Holstein cattle sourced from two commercial farms were
used as controls in the analyses. These control animals
were deemed free from any obvious disease by veterinary
examination.
Animal experimentation was carried out following in-
ternal ethical approval of the Istituto Sprimentale Zoo-
profilattico of Lombardy and Emilia Romagna, and in
compliance with the legislation pertinent at the time that
the BASE infection and sample collection was carried
out, namely European Directive 86/609 and the Italian
regulation dl 116/92. Experimental protocols were de-
signed to respect the principle of the 3Rs and to ensure
that any suffering was kept to a minimum. BASE chal-
lenged animals were inspected daily by qualified veterin-
ary staff for signs of distress, and culling of challenged
animals was carried out for sample collection for the
parent study using established humane procedures.
Fresh blood was centrifuged at 250 g for 20 minutes,
the buffy coat was transferred to a new tube and con-
taminating red blood cells were lysed with 10 ml of RBC
Lysis Solution (5 Prime). RNA was extracted immedi-
ately using TRI-reagent (Sigma-Aldrich) following the
instructions of the supplier. RNA obtained was quanti-
fied using a NanoDrop spectrophotometer (Thermo-
Scientific) and quality-checked using a Bioanalyser 2100
(Agilent).
Microarray and pathway analysis at 12 months post-
infection
Samples from 5 animals randomly chosen among the 11
challenged animals at 12 months post challenge (MPC),
together with samples from five breed, age and sex
matched healthy control Holstein cattle which were used
in the analysis.
About 1 μg of RNA was amplified and labelled with
Cy5-ULS following the manufacturer’s protocols
(ampULSe Cat. No. GEA-022; Kreatech biotechnology).
The purified aRNA was quantified using a NanoDrop
spectrophotometer and 4 μg were fragmented to a uni-
form size, then hybridized to a custom Bovine 90 K
array (see [27] for array details). The hybridized arrays
were scanned with a GenePix 4000B microarray scanner
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exported to the CombiMatrix Microarray Imager Software
for hybridization quality verification and spot definition.
Data were then extracted, loaded into R using the Limma
analysis package and signal intensities were analyzed using
the standard procedure of the Bioconductor suite [28]. The
list of differentially expressed (DE) genes was generated
using the linear modeling analysis in Limma, with an
adjusted P-value cut-off equal to 0.01.
A bioinformatics pipeline was created in PERL to
connect the gene ID (Ensembl ID, GenBank ID or Uni-
Prot ID) with known pathways, using the information
available from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database.
Gene expression along the time course of infection
Confirmation and time-course studies were performed
by quantitative reverse transcription PCR (qRT-PCR)
using samples from four of the five orally challenged
cattle used for the array analysis (insufficient material
was available from the 5th), and four different negative
control Holstein cows obtained from a second BSE
negative farm. The kinetics of expression of six selected
DE genes (TCR delta chain, TRAT1, CD3E, ZAP70, LAT
and LCK) was examined at 10, 12, 24 MPC.
RNA samples were treated with RNase-free DNase
(Sigma Aldrich) for 15 minutes at room temperature
and then used as a template for first-strand cDNA syn-
thesis using the SuperScript® III First-Strand Synthesis
System for RT-PCR (Invitrogen) according to the manu-
facturer’s instruction. Primers for qRT-PCR analysisTable 1 Primer used for qPCR
Gene Function
TCR delta chain Antigen receptor of T cells
TRAT1 TCR associated membrane adapter 1: TCR-mediated T ce
CD3E Marker of thymocytes and peripheral T lymphocytes
LAT Linker for activation of T cells, transduction of the activat
ZAP70 Associated with CD3Z chain; transduction of the activatio
LCK lymphocyte-specific protein tyrosine kinase
B2MG Beta-2-microglobulin precursor
ACTB Beta-Actin
B2MG and ACTB were used as internal controls.were designed using Primer Quest (Integrated DNA
Technologies) and are shown in Table 1.
Real Time PCR was performed on a Applied Biosystems
(ABI) PRISM 7900HT in 10 μl reactions containing 5 μl
of Power SYBR®Green (Applied Biosystems), 0.2 μl of each
primer at 10 μM and 3.6 μl of water. The thermal program
was, 95°C for 10 min, then 40 cycles of amplification in-
cluding two steps: 15 s at 95°C, 30s at 58°C, 30s at 60°C.
Each reaction was performed in triplicate.Results and discussion
Identification of differentially regulated genes, qRT-PCR
validation and pathway analysis
The analysis of gene expression in white blood cells
from 5 cattle 12 months after oral challenge with BASE,
identified 140 genes differentially expressed (DE)
between BASE challenged and control animals, with a
log2 fold change of 1.5 or greater and a p value < 0.01.
The majority of DE genes (91) were up-regulated in the
BASE animals compared with controls. Gene ontology
analysis using the KEGG Database identified 34 genes
that fell in 3 pathways each with several genes showing
affected expression (Tables 2, 3 and 4). The pathway
with the largest number of affected genes was related to
immune function (21) followed by signal transduction
and cell growth (8) then genes coding for metabolic pro-
teins (5). The microarray data set supporting the results
of this article is available in the NCBI GEO data reposi-
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Table 2 Differentially expressed Immune related genes
Sequence ID Gene name and function Log fold change P value
ENSBTAG00000005892 ZAP70, Zeta-chain (TCR) associated protein kinase 70 kDa 1.81 0.001924
ENSBTAG00000002259 TCRβ, T Cell Receptor Beta Chain 2.66 0.000014
ENSBTAG00000000431 TCRδ, T Cell Receptor Delta Chain 3.18 0.000025
ENSBTAG00000000183 TRAT1, T cell receptor associated transmembrane adaptor 1 2.26 0.000003
ENSBTAG00000011359 CD7, T Cell Antigen CD7 1.75 0.000607
ENSBTAG00000001002 TCF7, T Cell Specific Transcription factor 7 3 0.000025
ENSBTAG00000015710 CD3E, T Cell surface antigen CD3 epsilon chain 3.21 0.000010
ENSBTAG00000021249 LAT, Linker for activation of T cell 2.79 0.000010
ENSBTAG00000012695 LCK, lymphocyte-specific protein tyrosine kinase 1.54 0.000532
ENSBTAG00000006453 CD3g, , T Cell surface antigen CD3 gamma chain 2.11 0.000058
ENSBTAG00000030425 ID3, inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 1.97 0.000710
ENSBTAG00000005990 S1PR1, sphingosine-1-phosphate receptor 1 1.5 0.001691
ENSBTAG00000020319 ALOX5, arachidonate 5-lipoxygenase −1.85 0.002847
ENSBTAG00000011990 ALOX12, arachidonate 15-lipoxygenase −2.15 0.000439
ENSBTAG00000001321 Il1β, Interleukin 1 beta −1.91 0.000644
ENSBTAG00000019428 CCR1, chemokine (C-C motif) receptor 1 −1.41 0.001837
ENSBTAG00000038042 IL8βR, chemokine (C-X-C motif) receptor 2 (CXCR2) −1.96 0.004877
ENSBTAG00000003305 NCF1, neutrophilcytosolicfactor 1 −2.04 0.000868
ENSBTAG00000037735 C5L2, G protein-coupled receptor 77 (GPR77) −1.76 0.000958
ENSBTAG00000027051 PTAFR, platelet-activating factor receptor −1.41 0.000081
ENSBTAG00000004322 FOS, murine osteosarcoma viral oncogene homolog −1.57 0.000152
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expression 12 MPC with BASE
TCR signalling cascade
The pathway with most affected genes at 12 MPC was
related to immune function with 21 DE genes, of these
11 belonged to the TCR signalling cascade which regu-
lates the activation of T lymphocytes in response to
antigen presented by the Major Histocompatibility
Complex (MHC). Three genes involved in this pathway
with differential expression (TCRβ, TCRδ, and TRAT1)
were missing from the KEGG database for cow and
were added manually. The pan-T cell marker, CD7, and
the transcription factor TCF7/LEF were also added to
the TCR pathway by manual annotation. Ten of the DE
genes in the TCR cascade were up-regulated, several of
which had the highest log-fold change in expression ob-
served at 12 MPC. One gene, the transcription factorTable 3 Differentially expressed Metabolic Pathway genes
Sequence ID Gene name and function
ENSBTAG00000000065 (CRLS1), cardiolipinsynthase 1
ENSBTAG00000031814 SDH, serine dehydratase
ENSBTAG00000001154 DGAT2, diacylglycerol O-acyltransfe
ENSBTAG00000012855 LPL, lipoproteinlipase
ENSBTAG00000009733 F16P1, fructose-1,6-bisphosphataseFos, was down regulated, and is downstream of the sig-
nalling cascade.
Kinetics of expression for genes involved TCR signalling
in early phases of BASE infection
As TCR signaling is central to immune function and
was affected by BASE challenge, the expression of six
genes involved in this pathway (TCRδ, CD3E, ZAP70,
TRAT1, LAT, LCK) was analyzed over a time course
following BASE challenge (10-12-24 MPC) by qPCR.
The qPCR analysis confirmed the micro-array data for
TCRδ, CD3E, ZAP70 and TRAT1 which were overex-
pressed in BASE animals vs controls at 12 MPC (re-
spectively p < 0.01; p < 0.01; p < 0.01; p < 0.01). The LAT
gene also showed an increase of expression at 12 MPC
but the difference compared with controls was not
significant.Log fold change P value
1.52 0.0017
−3.55 0.0014
rase 2 −2.42 0.00044
−1.7 0.00045
1 (FBP1) −1.64 0.00733
Table 4 Other differentially expressed genes
Sequence ID Gene name and function Log fold change P value
ENSBTAG00000013761 STMN1, stathmin 1 1.66 0.00002
ENSBTAG00000008436 CDC25B, Cell division cycle 25B 2.01 0.00003
ENSBTAG00000009663 CSDA, cold shock domain protein A 1.7 0.00015
ENSBTAG00000007336 HCST, hematopoietic cell signal transducer 1.86 0.0003
ENSBTAG00000020350 DUSP2, dualspecificityphosphatase 2 −1.63 0.00264
ENSBTAG00000005947 PLAU, plasminogenactivator, urokinase −1.61 0.00012
ENSBTAG00000039657 H2A, Histone 2° −1.5 2.5E-05
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higher in all 4 infected animals examined by qPCR com-
pared with controls at all the time points post challenge.
TRAT1 and LAT showed the same trend, with an increase
in expression at 10 MPC and 12 MPC. TRAT 1 had statis-
tically significant increased expression at 12 MPC (p <
0.01), then fell to the same level as control samples by 24
MPC. LCK was found to be up-regulated 1.5 fold in the
microarray data at 12 MPC but in the qPCR analysis was
down-regulated at 12 MPC (p < 0.01), and also had lower
expression than controls at 10 and 24 MPC (see Figure 1).
Interestingly, PrPc has been found to co-precipitate with
the TCR [8,18] and with components of the TCR signaling
pathway [9], many of which appear among the DE genes
identified in the present study (ZAP70, LCK, CD3E, LAT).
The physiological function of PrPC is not fully understood,
however, it has been implicated in T cell activation after
the binding of the antigen [17]. T cell activation increases
PrPc concentration on the surface of human lymphocytes
[9]. In addition antibodies against PrPc block ConA in-
duced lymphocyte proliferation, which requires a func-
tional TCR complex [16]. How the function of PrP is
altered with the change in conformation from PrPc to
PrPres is unclear, although there are some suggestions that
there is a gain in function and not simply a loss. PrPres is
able to stimulate MAP kinase signaling in neuronal cells
whereas PrPC is not [29]. In, changes in the level of PrP
expression are likely to affect cell function e.g. lack of PrP
expression on antigen presenting cells affects T cell activa-
tion [30], whereas lack of PrP expression on the T cell itself
does not inhibit T cell activation. Nevertheless, the level of
PrP is increased following activation. Thus perturbed PrP
expression or function, as may occur in the change from
PrPC to PrPres, is likely to change the dynamics of T cell
activation and expression of genes associated with the T
cell receptor complex. In the present study, expression of
TCRδ, ZAP 70, CD3E, LCK and TRAT was found to
change between 10 and 24 month after the BASE chal-
lenge. qPCR analysis suggested that LCK was down regu-
lated during early infection (10–24 MPC), which is of
interest as this kinase is a key regulator of the TCR path-
way. Following the interaction between the TCR and CD3,LCK is recruited to the TCR complex, phosphorylates
downstream signaling molecules including ZAP70, and ac-
tivates a phosphorylation cascade that involves LAT and
TRAT [31,32]. This suggests that T cell response is indeed
affected following BASE challenge.
Genes linked to the inflammatory response
The data presented here also indicate that BASE challenge
of cattle is associated with a modified inflammatory re-
sponse. Expression of ALOX12 and ALOX5, which encode
proteins that are key effectors of an inflammatory response
were down-regulated at 12 MPC. ALOX12 and ALOX5
have a role in chemotaxis and response in tissue damage
[33] and are involved in Arachidonic acid metabolism,
which is necessary for Leukotrien production. Leukotriens
are key effectors of the inflammatory response [33] and
are produced by leukocytes, in particular mast-cells. C5L2
is one of the two receptors for the C5a anaphylotoxin, an
extremely potent pro-inflammatory peptide [34], which
was also down regulated following BASE challenge. Other
pro-inflammatory cytokines or their receptors (IL1β,
CCR1, IL8βR and NCF1) were also down-regulated.
Sphingosine 1-phosphate receptor 1 (S1PR1) was up-
regulated. S1PR1 is involved in the regulation of inflamma-
tory responses, cell migration and differentiation [35], and
the receptor for platelet activating factor (PTARF), a key
inflammatory mediator and a pattern recognition receptor
involved in the uptake of Gram-positive bacteria [36]. The
ID3 gene, which codes for an anti-inflammatory cytokine
involved in the TGFβ1 pathway, was also up-regulated.
The expression of genes in the TGFβ1 pathway has previ-
ously been reported to be up-regulated following prion in-
fection of mice and cattle [37,38]. The results presented
here are consistent with previous data, and suggest that
prion diseases are associated with an inhibition of inflam-
mation [8]. It is therefore interesting that the expression of
IL-8Rβ and NCF1, which are directly linked to chemotaxis
of neutrophils, was reduced in BASE challenged animals
compared with controls. These results are in agreement
with previous studies which proposed that PrPc has a role
in the modulation of inflammation and phagocytosis [8],
which was also seen in studies of PrP null mice [8].
Figure 1 Kinetics of expression for genes involved in the TCR pathway. Results from qPCR analysis of the expression of six genes (TRD, CD3E,
TRAT, LAT, LCK, ZAP70) involved in TCR signaling in circulating immune cells, in control animals (T0) and BASE challenged animals at 10-12-24
months post challenge (T10, T12 and T14 respectively). Each column represents the mean ± SEM of at least three separate measurements on 4
individuals. The expression of mRNA normalized to two endogenous reference genes (β-Actin and β-2 Microglobulin), was analyzed by RT-PCR
using specific primers as described in Material and Methods. The different superscripts indicate significant difference between columns (p < 0.01).
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HCST, a signal transduction protein involved in NK and
T cell activity, especially during anti-viral responses, was
up-regulated.
Metabolic and signal transduction genes of WBC affected
by BASE at 12 months post-challenge
In addition to immune function related genes, other
pathways were affected by BASE infection, includinggenes involved in energy metabolism and signal trans-
duction, which are discussed here for completeness.
Energy metabolism and storage
Several genes involved in energy metabolism and storage
of carbohydrates (F16P1, SDHL) and also genes regulat-
ing lipid metabolism and signalling (DGAT2, LIPL), were
down regulated in BASE challenged cattle compared with
controls at 12 MPC. However, cardiolipin synthase 1
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function and is predominantly expressed by tissues with
high levels of energy metabolism, was up-regulated.
SDHL, which is associated with energy balance, has previ-
ously been shown to be affected by TSE diseases. Previ-
ous work has shown that proteins related to glucose
metabolism have aberrant expression in cerebrospinal
fluid of sCJD patients [39]. Patients with sporadic CJD
have also been shown to have altered levels of proteins
associated with the control of glucose [39] and lipid [37]
metabolism. Changes in glucose metabolism are known
to trigger apoptotic pathways [39] while changes in lipid
metabolism and signalling are one of the early changes
apparent in many neurodegenerative diseases, including
prion diseases [37]. Therefore this response, while linked
to BASE challenge in this study, is not likely to be specific
for prion disease.Cell signalling genes
Two genes involved in signal transduction (STMN1,
CDC25B), which code for proteins of the MAP kinase
pathway (MAPK), were up-regulated, while a negative
regulator of this pathway (DUSP2) was down-regulated
in challenged animals at 12 MPC. MAPK pathways are
essential for cell survival and were up regulated. It has
been suggested that MAPK has a role in the protective
response to cellular oxidative stress [40]. Previous stud-
ies have reported that MAPK proteins interact with PrPc
[41]. These genes are also known to play an active role
in prion disease pathogenesis in nervous tissues and the
medulla, with the sequential activation of the various
MAPK associated genes during PrPres deposition [37,40].
MAPK pathway genes have been shown to be up regu-
lated in brain tissues of scrapie infected hamster [40] and
mice [37], and in the medulla of cattle following oral chal-
lenge with BSE [38]. This is consistent with data which
showed that PrPc interacts with MAPK proteins [41].
Genes in other signal transduction pathways also
showed changes in expression 12 MPC. CSDA is a
member of the highly conserved Cold Shock Domain
family of DNA binding proteins which is involved in
post-transcriptional control of gene expression [42,43]
and was up regulated. The gene coding for histone H2A
was down-regulated. Histone 2A is known to co-purify
with PrPres extracted from the brains of hamsters in-
fected with experimental scrapie [44].Coagulation cascade
Expression of the gene coding for thrombin receptor
(F2R) was up regulated, while the plasminogen activator
urokinase (PLAU), was down-regulated. Expression of
genes involved in coagulation have also been shown to
be affected in the brain of cattle incubating BSE [38].The BASE challenged animals used for the expression
analysis remained healthy up to the 24 month time-point
examined here. The parent study which provided the
samples in still in progress, and therefore further infor-
mation on the health status of the animals is not yet
available. Data presented here are consistent with that
from the earlier study [27], and all animals studied
displayed a consistent change in gene expression in com-
parison with controls, suggesting that they were respond-
ing to the BASE challenge. It should also be noted that
while challenged animals were housed in a containment
facility, controls were taken from two commercial
farms. Hence controls and challenged animals experi-
enced different environments, which may have resulted
in differences in expression patterns. DE genes between
the challenged animals and controls were consistent
between the two control groups, which experienced
different management regimes. The DE genes and path-
ways identified between controls and challenged animals
are consistent with those reported in other TSE infection
models as discussed above. This give some confidence in
these data and that the effects of orally administered
BASE on gene expression are similar to other TSEs.
Conclusions
The data presented here on gene expression in circulat-
ing immune cells following BASE challenge show that
response to BASE has similarities with other prion
diseases. PrPc is known to have a role in the immune
system, indeed it is expressed on DC and is important
for inducing the T cell proliferative response [30]. More-
over, PrPc accumulates in the contact point between T
cells and DC, and it may have a role in the assembly of
the TCR complex [45]. The disease form of this protein
(PrPres) has been shown to affect the immune system,
e.g. eliciting qualitative differences in the responses of T
cells [46]. Moreover, macrophages accumulate PrPres,
and may be involved in the transfer of the disease to the
CNS [9,47]. The data presented here are consistent with
the hypothesis that the effects of TSE diseases are not
limited to CNS, but involve the immune system, espe-
cially during the early stages following challenge, before
the appearance of clinical signs. Our data suggest that
BASE challenge affects the TCR signalling pathway,
which has also been shown in mouse knock-out experi-
ments [17]. BASE therefore, in common with other
prion diseases, seems to be associated with general cellu-
lar stress and impaired immune function. These data,
from experimentally challenged cattle, suggest that orally
administered BASE affects gene expression in circulating
immune cells even in the absence of overt disease.
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